Don’t see what you’re looking for? Use the search box on MDA’s Quest magazine.
Posted on Wednesday, May 1, 2013 - 09:23, By: Amy Madsen
Update (Feb. 4, 2014): This trial is now closed to new participants.
Name: Ozanezumab (GSK1223249)
How it works: Ozanezumab, developed by GlaxoSmithKline, is thought to work by helping protect neuromuscular junctions, where muscles interact with nerves. The drug may help repair damaged axons, the...